Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)
Apply
Niraparib & Dostarlimab
Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step